Skip to content
Back to MIRM

Mirum Pharmaceuticals, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
64
Purchases
1
Sales
63
Purchase value
$9.00M
Sale value
$44.85M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Saira RamasastryDirector
4Rule 10b5-1 plan disclosed
Filed Nov 17, 2026Period of report Nov 16, 20260001547959-26-000019
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 16, 2026
Common StockF12,000$92.28$184.56K0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 10, 2026.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Laura BregeDirector
4
Filed Nov 13, 2026Period of report Nov 11, 20250001365619-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 11, 2026
Common StockF110,907$94.05$1.03M18,963Direct
SaleNov 11, 2026
Common StockF23,260$94.74$308.85K15,703Direct
Filing footnotes · 3
  1. F1The weighted average sale price for the transaction reported was $94.05, and the range of prices were between $93.63 and $94.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  2. F2The weighted average sale price for the transaction reported was $94.74, and the range of prices were between $94.635 and $94.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. F3The stock option is fully vested.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4Rule 10b5-1 plan disclosed
Filed Nov 4, 2026Period of report Nov 4, 20260001614740-26-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 4, 2026
Common StockF120,000$90.00$1.80M206,637Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Eric BjerkholtCHIEF FINANCIAL OFFICER
4
Filed Sep 15, 2026Period of report Sep 11, 20260001197350-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 14, 2026
Common StockF29,943$98.37$978.09K44,745Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F3The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4Rule 10b5-1 plan disclosed
Filed Sep 3, 2026Period of report Sep 2, 20260001974200-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 2, 2026
Common StockF1658$100.00$65.80K616Direct
Filing footnotes · 1
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4Rule 10b5-1 plan disclosed
Filed Sep 3, 2026Period of report Sep 1, 20260001614740-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 1, 2026
Common StockF2F38,312$98.08$815.24K216,128Direct
SaleSep 1, 2026
Common StockF2F421,688$98.91$2.15M194,440Direct
Filing footnotes · 5
  1. F1Includes 131 shares of Common Stock that were acquired by the Reporting Person on May 10, 2026, pursuant to the Issuer's Employee Stock Purchase Plan.
  2. F2Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.
  3. F3The weighted average sale price for the transaction reported was $98.08, and the range of prices were between $97.47 and $98.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. F4The weighted average sale price for the transaction reported was $98.91, and the range of prices were between $98.49 and $99.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  5. F5The stock option is fully vested.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4
Filed Aug 19, 2026Period of report Aug 18, 20260001974200-26-000012
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common Stock40,000$100.00$4.00M1,274Direct
Filing footnotes · 1
  1. F1The stock option is fully vested.
Open on SEC EDGAR
Eric BjerkholtCHIEF FINANCIAL OFFICER
4Rule 10b5-1 plan disclosed
Filed Aug 12, 2026Period of report Aug 11, 20260001197350-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 11, 2026
Common StockF1F2F36,001$99.9016$599.51K36,355Direct
Filing footnotes · 3
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026.
  2. F2. The weighted average sale price for the transaction reported was $99.901633, and the range of prices were between $99.90 and $99.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. F3Includes 175 shares of common stock that were acquired by the Reporting Person on May 10, 2026, pursuant to the Issuer's Employee Stock Purchase Plan.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4Rule 10b5-1 plan disclosed
Filed Aug 11, 2026Period of report Aug 10, 20260001614740-26-000012
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 10, 2026
Common StockF1F211,683$98.51$1.15M202,626Direct
SaleAug 10, 2026
Common StockF1F36,017$99.25$597.19K196,609Direct
SaleAug 10, 2026
Common StockF1F42,300$100.14$230.32K194,309Direct
Filing footnotes · 5
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.
  2. F2The weighted average sale price for the transaction reported was $98.51, and the range of prices were between $97.93 and $98.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. F3The weighted average sale price for the transaction reported was $99.25, and the range of prices were between $98.94 and $99.655. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. F4The weighted average sale price for the transaction reported was $100.14, and the range of prices were between $99.995 and $100.2425. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  5. F5The stock option is fully vested.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 3, 20260001974200-26-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common StockF11,840$105.29$193.73K1,274Direct
Filing footnotes · 1
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4Rule 10b5-1 plan disclosed
Filed Jul 8, 2026Period of report Jul 6, 20260001614740-26-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common StockF1F212,134$121.65$1.48M202,175Direct
SaleJul 6, 2026
Common StockF1F34,181$122.34$511.50K197,994Direct
SaleJul 6, 2026
Common StockF1F41,975$123.74$244.39K196,019Direct
SaleJul 6, 2026
Common StockF1F51,710$124.79$213.39K194,309Direct
Filing footnotes · 6
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.
  2. F2The weighted average sale price for the transaction reported was $121.65, and the range of prices were between $121.11 and $122.105. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. F3The weighted average sale price for the transaction reported was $122.34, and the range of prices were between $122.13 and $123.1125. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. F4The weighted average sale price for the transaction reported was $123.74, and the range of prices were between $123.24 and $124.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  5. F5The weighted average sale price for the transaction reported was $124.79, and the range of prices were between $124.27 and $124.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  6. F6The stock option is fully vested.
Open on SEC EDGAR
Eric BjerkholtCHIEF FINANCIAL OFFICER
4Rule 10b5-1 plan disclosed
Filed Jul 8, 2026Period of report Jul 6, 20260001197350-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common StockF1F23,124$121.67$380.10K44,057Direct
SaleJul 6, 2026
Common StockF1F31,048$122.43$128.31K43,009Direct
SaleJul 6, 2026
Common StockF1F4528$123.84$65.39K42,481Direct
SaleJul 6, 2026
Common StockF1300$124.94$37.48K42,181Direct
Filing footnotes · 4
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026.
  2. F2. The weighted average sale price for the transaction reported was $121.67, and the range of prices were between $121.13 and $122.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. F3. The weighted average sale price for the transaction reported was $122.43, and the range of prices were between $122.235 and $123.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. F4. The weighted average sale price for the transaction reported was $123.84, and the range of prices were between $123.285 and $124.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4Rule 10b5-1 plan disclosed
Filed Jul 2, 2026Period of report Jul 1, 20260001974200-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF12,721$120.00$326.52K3,114Direct
Filing footnotes · 1
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4Rule 10b5-1 plan disclosed
Filed Jun 18, 2026Period of report Jun 17, 20260001974200-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 17, 2026
Common StockF12,594$101.95$264.46K5,835Direct
Filing footnotes · 1
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026.
Open on SEC EDGAR
Eric BjerkholtCHIEF FINANCIAL OFFICER
4Rule 10b5-1 plan disclosed
Filed Jun 9, 2026Period of report Jun 8, 20260001197350-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 8, 2026
Common StockF1F22,258$92.84$209.63K47,530Direct
SaleJun 8, 2026
Common StockF1F31,175$93.95$110.39K46,355Direct
SaleJun 8, 2026
Common StockF1F41,567$95.12$149.05K44,788Direct
Filing footnotes · 5
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026.
  2. F2. The weighted average sale price for the transaction reported was $92.84, and the range of prices were between $92.485 and $93.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. F3. The weighted average sale price for the transaction reported was $93.95, and the range of prices were between $93.49 and $94.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. F4. The weighted average sale price for the transaction reported was $95.12, and the range of prices were between $94.62 and $95.44. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  5. F51/4th of the shares vested one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4Rule 10b5-1 plan disclosed
Filed Jun 2, 2026Period of report Jun 1, 20260001614740-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF1F22,602$94.64$246.25K221,707Direct
SaleJun 1, 2026
Common StockF1F316,595$95.34$1.58M205,112Direct
SaleJun 1, 2026
Common StockF1F46,926$96.15$665.93K198,186Direct
SaleJun 1, 2026
Common StockF1F51,973$97.56$192.49K196,213Direct
SaleJun 1, 2026
Common StockF1F61,021$98.20$100.26K195,192Direct
SaleJun 1, 2026
Common StockF1F7883$99.66$88.00K194,309Direct
Filing footnotes · 8
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.
  2. F2The weighted average sale price for the transaction reported was $94.64, and the range of prices were between $93.90 and $94.895. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. F3The weighted average sale price for the transaction reported was $95.34, and the range of prices were between $94.91 and $95.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. F4The weighted average sale price for the transaction reported was $96.15, and the range of prices were between $95.92 and $96.8675. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  5. F5The weighted average sale price for the transaction reported was $97.56, and the range of prices were between $96.98 and $97.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  6. F6The weighted average sale price for the transaction reported was $98.20, and the range of prices were between $98.00 and $98.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  7. F7The weighted average sale price for the transaction reported was $99.66, and the range of prices were between $99.55 and $99.79. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  8. F8The stock option is fully vested.
Open on SEC EDGAR
Saira RamasastryDirector
4
Filed Jun 2, 2026Period of report May 29, 20260001547959-26-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF23,977$100.00$397.70K0Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
  3. F3Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests on May 29, 2026.
Open on SEC EDGAR
Saira RamasastryDirector
4Rule 10b5-1 plan disclosed
Filed May 18, 2026Period of report May 15, 20260001547959-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 15, 2026
Common StockF12,000$109.47$218.94K0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Saira RamasastryDirector
4Rule 10b5-1 plan disclosed
Filed Apr 16, 2026Period of report Apr 15, 20260001547959-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 15, 2026
Common StockF12,000$96.90$193.80K0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4
Filed Mar 17, 2026Period of report Mar 15, 20260001974200-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF24,732$91.9779$435.24K8,429Direct
Filing footnotes · 4
  1. F1Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
  3. F3The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026.
  4. F4The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.
Open on SEC EDGAR
Joanne QuanCHIEF MEDICAL OFFICER
4
Filed Mar 17, 2026Period of report Mar 15, 20260001670138-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF27,287$91.9779$670.24K18,864Direct
Filing footnotes · 3
  1. F1Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
  3. F3The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.
Open on SEC EDGAR
Peter RadovichPRESIDENT AND COO
4
Filed Mar 17, 2026Period of report Mar 15, 20260001650131-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF216,515$91.9779$1.52M40,272Direct
Filing footnotes · 4
  1. F1Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
  3. F3The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026.
  4. F4The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4
Filed Mar 17, 2026Period of report Mar 15, 20260001614740-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF240,985$91.9779$3.77M194,309Direct
Filing footnotes · 4
  1. F1Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
  3. F3The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026.
  4. F4The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.
Open on SEC EDGAR
Saira RamasastryDirector
4Rule 10b5-1 plan disclosed
Filed Mar 17, 2026Period of report Mar 16, 20260001547959-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF12,000$90.76$181.52K0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Eric BjerkholtCHIEF FINANCIAL OFFICER
4
Filed Mar 17, 2026Period of report Mar 15, 20260001197350-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF27,287$91.9779$670.24K49,788Direct
Filing footnotes · 3
  1. F1Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
  3. F3The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.
Open on SEC EDGAR
Saira RamasastryDirector
4Rule 10b5-1 plan disclosed
Filed Feb 17, 2026Period of report Feb 13, 20260001547959-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 13, 2026
Common StockF12,000$102.09$204.18K0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4
Filed Feb 3, 2026Period of report Jan 31, 20260001974200-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 2, 2026
Common StockF2968$103.3035$100.00K4,503Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F3The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026.
Open on SEC EDGAR
Peter RadovichPRESIDENT AND COO
4
Filed Feb 3, 2026Period of report Feb 2, 20260001650131-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 2, 2026
Common StockF12,631$103.3035$271.79K20,655Direct
Filing footnotes · 1
  1. F1Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4
Filed Feb 3, 2026Period of report Feb 2, 20260001614740-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 2, 2026
Common StockF19,108$103.3035$940.89K160,294Direct
Filing footnotes · 1
  1. F1Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4
Filed Jan 27, 2026Period of report Jan 23, 20260001974200-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 26, 2026
Common StockF2842$96.192$80.99K3,700Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F31/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Peter RadovichPRESIDENT AND COO
4
Filed Jan 27, 2026Period of report Jan 23, 20260001650131-26-000003
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 26, 2026
Common StockF23,143$96.192$302.33K23,286Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F31/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4
Filed Jan 27, 2026Period of report Jan 23, 20260001614740-26-000003
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 26, 2026
Common StockF26,831$96.192$657.09K169,402Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F31/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Eric BjerkholtCHIEF FINANCIAL OFFICER
4
Filed Jan 27, 2026Period of report Jan 23, 20260001197350-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 26, 2026
Common StockF2F11,053$96.192$101.29K43,741Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F31/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Patrick J HeronDirector
4
Filed Jan 27, 2026Period of report Jan 23, 20260001365617-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJan 23, 2026
Common StockF2131,425$68.48$9.00M459,010IndirectBy Frazier Life Sciences X, L.P.
Filing footnotes · 3
  1. F1Frazier Life Sciences X, L.P. received these shares in connection with merger of Bluejay Therapeutics, Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's Common Stock was $94.29 per share.
  2. F2The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  3. F3The shares are held directly by Frazier Life Sciences IX, L.P. FHMLS IX, L.P. is the general partner of Frazier Life Sciences IX, L.P. FHMLS IX, L.L.C. is the general partner of FHMLS IX, L.P. The Reporting Person is one of two managing members of FHMLS IX, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
Jolanda HoweSVP, GLOBAL CONTROLLER
4
Filed Jan 23, 2026Period of report Jan 21, 20260001974200-26-000001
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 22, 2026
Common StockF2926$93.3252$86.42K3,042Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F31/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Joanne QuanCHIEF MEDICAL OFFICER
4
Filed Jan 23, 2026Period of report Jan 21, 20260001670138-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 22, 2026
Common StockF2F11,822$93.3252$170.04K12,817Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F31/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Peter RadovichPRESIDENT AND COO
4
Filed Jan 23, 2026Period of report Jan 21, 20260001650131-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 22, 2026
Common StockF32,382$93.3252$222.30K20,679Direct
Filing footnotes · 4
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Includes 222 shares of common stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan.
  3. F3Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  4. F41/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Christopher PeetzDirector · CHIEF EXECUTIVE OFFICER
4
Filed Jan 23, 2026Period of report Jan 21, 20260001614740-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 22, 2026
Common StockF27,098$93.3252$662.42K163,733Direct
Filing footnotes · 3
  1. F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. F2Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. F31/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Eric BjerkholtCHIEF FINANCIAL OFFICER
4
Filed Jan 23, 2026Period of report Jan 21, 20260001197350-26-000001
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 22, 2026
Common StockF3F11,421$93.3252$132.62K42,127Direct
Filing footnotes · 4
  1. F1Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. F2Includes 269 shares of common stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan.
  3. F3Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  4. F41/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Joanne QuanCHIEF MEDICAL OFFICER
4
Filed Jan 21, 2026Period of report Jan 16, 20260001670138-26-000001
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 20, 2026
Common StockF36,911$90.2696$623.85K11,305Direct
Filing footnotes · 4
  1. F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. F2Includes 67 shares of common stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan.
  3. F3Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  4. F41/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Open on SEC EDGAR
Saira RamasastryDirector
4Rule 10b5-1 plan disclosed
Filed Jan 16, 2026Period of report Jan 15, 20260001547959-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 15, 2026
Common StockF12,000$90.99$181.98K0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Saira RamasastryDirector
4Rule 10b5-1 plan disclosed
Filed Dec 23, 2025Period of report Dec 22, 20250001547959-25-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 22, 2025
Common StockF15,000$80.00$400.00K0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Michael G GreyDirector
4Rule 10b5-1 plan disclosed
Filed Dec 23, 2025Period of report Dec 19, 20250001240122-25-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 19, 2025
Common StockF150,000$78.00$3.90M0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 22, 2025.
  2. F2The stock option is fully vested and exercisable.
Open on SEC EDGAR
Saira RamasastryDirector
4Rule 10b5-1 plan disclosed
Filed Dec 19, 2025Period of report Dec 18, 20250001547959-25-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 18, 2025
Common StockF11,000$69.46$69.46K1,000Direct
SaleDec 18, 2025
Common StockF11,000$70.00$70.00K0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
  2. F2The stock option is fully vested.
Open on SEC EDGAR
Michael G GreyDirector
4Rule 10b5-1 plan disclosed
Filed Dec 2, 2025Period of report Dec 1, 20250001240122-25-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 1, 2025
Common StockF150,000$74.00$3.70M0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 22, 2025.
  2. F2The stock option is fully vested and exercisable.
Open on SEC EDGAR
Michael G GreyDirector
4Rule 10b5-1 plan disclosed
Filed Nov 25, 2025Period of report Nov 21, 20250001240122-25-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 21, 2025
Common StockF150,000$70.00$3.50M0Direct
Filing footnotes · 2
  1. F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 22, 2025.
  2. F2The stock option is fully vested and exercisable.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.